Clinical Trial Update: Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION) [Phase 1]

View source ↗

Summary

ENVISION is a Phase 1 trial evaluating the safety of RTx-015 injection in patients with retinitis pigmentosa or choroideremia; the study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroideremia
• Retinitis Pigmentosa

Drugs mentioned

• RTx-015

Snippet

Sponsor: Ray Therapeutics, Inc. | Conditions: Retinitis Pigmentosa, Choroideremia | Phase 1 | Status: ACTIVE_NOT_RECRUITING